Sato J, Nioka M, Owada E, Ito K, Murata T
J Pharmacobiodyn. 1981 Dec;4(12):952-60. doi: 10.1248/bpb1978.4.952.
Effect of acetazolamide (AZA) on the anticonvulsant potency of phenobarbital (PHB) was investigated in mice by maximal electroshock seizure (MES) test. By coadministration with AZA, a remarkable increase an prolongation of the anticonvulsant activity of PHB was brought about. The type of the synergism of PHB with AZA was not additive but of potentiation. The potentiation of the anticonvulsant activity of PHB with AZA was rather related to inhibition of carbonic anhydrase (CA) in brain than in blood. The anticonvulsant activity of PHB was also increased by coadministration with methazolamide which had a great ability to inhibit brain CA. Furosemide, which had no inhibitory effect on brain CA, on the other hand, failed to show any potentiation on the anticonvulsant activity of PHB. Thus it was inferred that the inhibition of brain CA may play a significant role for the potentiation of the anticonvulsant activity of PHB. Although reserpinization completely abolished the protective effect of AZA on MES, the potentiation of the anticonvulsant activity of PHB was still observed by AZA. These results suggest that pharmacodynamic and/or pharmacokinetic effect of AZA independent of its anticonvulsant action may contribute to the potentiation of the PHB action.
通过最大电休克惊厥(MES)试验,在小鼠中研究了乙酰唑胺(AZA)对苯巴比妥(PHB)抗惊厥效力的影响。通过与AZA联合给药,PHB的抗惊厥活性显著增强并延长。PHB与AZA的协同作用类型不是相加性的,而是增效性的。PHB与AZA的抗惊厥活性增效作用与其对脑而非血液中碳酸酐酶(CA)的抑制作用有关。与具有强大脑CA抑制能力的甲醋唑胺联合给药时,PHB的抗惊厥活性也增强。另一方面,对脑CA无抑制作用的呋塞米未能显示出对PHB抗惊厥活性的任何增效作用。因此可以推断,脑CA的抑制可能对PHB抗惊厥活性的增效起重要作用。尽管利血平化完全消除了AZA对MES的保护作用,但AZA仍能观察到PHB抗惊厥活性的增效作用。这些结果表明,AZA独立于其抗惊厥作用的药效学和/或药代动力学效应可能有助于增强PHB的作用。